Small Activating RNAs: Towards Development of New Therapeutic Agents and Clinical Treatments

Author(s): Sen-Mao Li, Jia Hu*.

Journal Name: Current Pharmaceutical Biotechnology

Volume 19 , Issue 8 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Background: Small double-strand RNAs (dsRNAs) molecules are able to activate endogenous genes via an RNA-based promoter-targeting mechanism. Like RNA interference (RNAi), RNA activation (RNAa) is an evolutionarily conserved mechanism that is present in diverse eukaryotic organisms ranging from yeast to humans.

Methods: The small activating RNAs (saRNAs) that are involved in RNAa have been successively used to activate gene expression in cultured cells. Thus, this emergent technique might allow us to develop biotechnological and therapeutic applications without the need to synthesize hazardous construct systems that harbor exogenous DNA sequences.

Result and Conclusion: Accordingly, this article aims to provide insights into how RNAa cellular machinery can be manipulated to activate gene expression and for more effective clinical treatments of diverse diseases.

Keywords: RNAa, targeted gene overexpression, dsRNAs, argonaute, epigenetic information systems, clinical therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [622 - 630]
Pages: 9
DOI: 10.2174/1389201019666180802145134
Price: $65

Article Metrics

PDF: 33